Delivery Order SPE2DB22D2206-SPE2DB24FEB35
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml. The contract has a ceiling value of $3,531.45 and a completion date of March 18, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-pak 18 mg/3 ml pens. The contract has a firm fixed price ceiling value of $3,812.88 and an ultimate completion date of February 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Victoza 3-Pak 18 mg/3 ml pen, a medication used to treat diabetes. The delivery order contract is valued at $6,404.26 and has a completion date of October 6, 2023. The contract is a firm fixed-price, delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $2,154.27, is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the...
- This federal contract award is for the delivery of the pharmaceutical product Victoza 3-Pak 18 mg/3 ml Pen 3 ml. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,251.87 and an ultimate completion date of March 27, 2023. The contract is a Delivery Order placed against an Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Victoza 2-Pak 18 mg/3 ml Pen 3 ml. The contract has a ceiling value of $3,536.79 and was awarded on August 2, 2022, with an ultimate completion date of August 3, 2022. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide the Victoza 2-Pak 18 mg/3 ml pen medication. The $1,771.72 award has a performance period through January 13, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This federal contract award is for the delivery of Victoza brand pharmaceutical products, specifically 3-paks of 18 mg/3 mL pens, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,310.90 and a completion date of February 3, 2022. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This federal contract award, valued at $4,112.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml, a prescription medication. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Victoza 3-Pak 18 mg/3 ml pen 3 ml. The contract, valued at $2,489.04, is a firm fixed price delivery order with a completion date of February 28, 2022. The contract is not designated as a set-aside and was awarded through open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEB35Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-Pak 18 mg/3 ml pen. The contract has a ceiling value of $1,638.76 and a completion date of November 8, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award represents a specific delivery order under that IDC for the procurement of the Victoza medication.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/7/23 |